companydata.dkHemab ApS: Financial statements 2024
CVR: 40837590
Hemab ApS (CVR 40837590) has filed annual accounts for 2024. Equity amounted to DKK 104,000. The company had 36 employees in the financial year.
- Equity
- 104,000 kr.
- Employees
- 36
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | - | - | 104 t. | 36 |
| 2023 | - | - | -22.8 mio. | 136.2 mio. | 21 |
| 2022 | - | - | -156.4 mio. | 6.1 mio. | 10 |
| 2021 | - | - | -35.2 mio. | 68 mio. | 3 |
How creditworthy is Hemab ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
Hemab ApS has published its annual report for 2023. The net result was DKK -22,783,000.
As of January 16, 2024, Akshay Krishnadas Vaishnaw has joined the board of directors of Hemab ApS.
About Hemab ApS
Hemab ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Ebumab Hemophilia ApS. The management consists of Benny Sørensen and Mads Nikolaj Behrndt-Eriksen. The company is owned by Hemab Therapeutics Holdings, Inc.. Equity amounted to DKK 196,000.